---
schema_version: "secwatch.filing_event.v1"
accession: "0000313616-25-000155"
form_type: "8-K"
ticker: "DHR"
cik: "0000313616"
company_name: "DANAHER CORP /DE/"
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T02:44:14.501781+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Danaher names Matthew Gugino as CFO effective Feb 28, 2026; McGrew to remain EVP

## Summary
- Matthew M. McGrew to step down as CFO effective Feb 28, 2026, continue as Executive Vice President.
- Matthew E. Gugino, currently Group CFO of Life Sciences Innovations, appointed CFO effective Feb 28, 2026.
- Gugino's base salary increases to $700k now, $825k upon CFO start; equity target $4.2M in 2026.
- McGrew's 2026 compensation: base salary $700k, target bonus 125%, equity $2.5M.
- Gugino joined Danaher in 2013; previously at Barclays, Morgan Stanley, KPMG.

## SEC filing metadata
- accession: 0000313616-25-000155
- form_type: 8-K
- ticker: DHR
- cik: 0000313616
- company_name: DANAHER CORP /DE/
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313616/000031361625000155/0000313616-25-000155-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313616/000031361625000155/dhr-20250721.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313616-25-000155
- JSON: https://secwatch.observer/filing/0000313616-25-000155.json
- Plain text: https://secwatch.observer/filing/0000313616-25-000155.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.